Skip to main content
GMP Scientist with TC flask and media pipette

Clinical Stem Cell Services

Stem Cell Services for Cell Therapy Manufacturing

Developing cellular therapies requires strict adherence to manufacturing and regulatory standards that are different for each national regulatory agency. REPROCELL can help you through all stages of your regenerative medicine project.

Cell-based therapies have significant potential to provide patient relief in a broad range of disease areas, from cancer to degenerative disorders. Many of these projects start with iPSCs (induced pluripotent stem cells) or with MSCs (mesenchymal stem cells). Master cell banks (MCBs) can be effectively generated from these stem cells therefore ensuring product consistency while managing risk by eliminating contamination and genetic instability.

Our clinical stem cell services:

Specifically, iPSCs are straightforward to genetically manipulate, and they open the path for innovative therapeutics such as gene correction for the therapeutic rescue of genetic diseases, the addition of genes at precise genome sites, or the creation of hypoimmune lines that can overcome HLA mismatches.

Whether your project starts with iPSCs or MSCs as the source for your stem cell-based therapeutic project, or if you are interested in clinical gene editing, REPROCELL can assist you!

REPROCELL is a global company that serves customers all around the world. Our worldwide presence ensures that our client's cell therapy projects are compliant with the regulatory standards and guidelines of the FDA, EMA, and PMDA. We will provide the necessary quality and regulatory documents including donor eligibility, CoAs, batch records, traceability documentation, and quality technical agreements for your GMP Master Cell Bank or cell therapy product.

REPROCELL’s Clinical Stem Cell Services

Tissue culture flask and media pipetting

Clinical iPSC production service

REPROCELL can provide you with clinical iPSCs for your therapeutic project, created with our state-of-the-art RNA reprogramming technology. You can test our clonal lines for suitability before scaling up to a GMP Master Cell Bank.

Tissue culture flask and media pipetting

Clinical MSC production service

Whatever the source of MSCs or derivatives thereof you need, REPROCELL can help you drive your next clinical MSC project to success and ensure compliancy with regulatory agencies.


Ready to use GMP Mesenchymal Stem Cells

High-quality GMP Mesenchymal Stem Cells (MSCs, also called “Mesenchymal Stromal Cells”) provided in partnership with Cellcolabs in Solna, Sweden.

crispr cas gene editing dna

StemEdit clinical gene editing service

Using CRISPR-SNIPER, our StemEdit clinical gene editing service enables you to achieve the genotype you need before moving on to expensive cell bank manufacturing processes.

Find out more about REPROCELL’s Clinical iPSCs and MSCs


Review article (offsite)

How to find the right end-to-end developer for manufacturing your cGMP-compatible iPSCs

From β-islets for diabetes to dopaminergic neurons for Parkinson’s disease, induced pluripotent stem cell (iPSC)-derived, haplotyped, and multiplex-engineered allogeneic cell therapeutics empower the development of effective and safe Cell and Gene Therapy Products (CGTs) that could be manufactured on a large scale in a cost-effective manner and provide a functional cure for diseases that plague humankind today.


Review article (offsite)

Making iPSC-derived therapies a clinical reality

Since their invention in 2006, induced pluripotent stem cells (iPSCs) have revolutionized how researchers approach disease modelling, drug discovery research, and drug development. Derived from adult somatic stem cells rather than embryos, iPSCs have allowed scientists to study human biology with increased depth, reproducibility, scalability, and translatability. This is especially true for diseases where animal models lack clinical relevance, and where primary tissues are difficult to access.

Stem Cell Research and Technology

Things to consider when searching for a supplier of cGMP iPSCs

Dr Mahendra Rao

Production of Mesenchymal Stem Cells (MSCs) for Clinical and Research Projects

Evelyn Chukwurah, Ph.D.
Naiarah de Paz, M.Sc.
(COO, Histocell)

Are you looking for something else?

In addition to our clinical GMP iPSC production and GMP MSC production services, we have a range of other stem cell services and products.

Make an Inquiry

At REPROCELL, our scientists understand that your custom gene editing project must be as unique as your research. If you have any questions about our CRISPR-SNIPER service, please make an inquiry using the form below.